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Oral Immunization of Wildlife Against Rabies:
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A. I. Wandeler, S. Capt, A. Kappeler, and R. Hauser From the Swiss Rabies Centre. Institute of Veterinary
Virology, University of Bern, Bern. Switzerland
The possibility of immunizing carnivores against rabies with live attenuated vaccine ad-
ministered by the oral route was raised by North American scientists in the 1960s. Subse-
quently, several American and European teams tested different vaccine strains in the lab-
or~tory for efficacy a~d saf~ty and studied vaccine stabilization, vaccine delivery systems,
baIt acceptance by wl1d ammals, and bait distribution schemes. The first field trial of
a cloned SAD (Street Alabama Dufferin) strain in baits designed to immunize foxes orally
~as conducted in an Alpine valley in Switzerland in 1978. A population containing f\J60ltJo
Immune foxes at the valley entrance stopped the spread of the disease into untreated up-
per pa~ts of the valley. T~e strategic use of oral vaccination of foxes in additional regions
of SWItzerland resulted m freedom from the zoonosis in four-fifths of the country.
The control of dog rabies by immunization has been
successful since effective vaccines for veterinary use
became available and were applied in mass vaccina-
tion campaigns. In many parts of the world, how-
ever, rabies remains endemic in populations of wild
mammals. The idea of vaccinating susceptible free-
living species suggests itself, but most early attempts
at establishing herd immunities at a reasonable level
in populations of wild carnivores failed [1]. Obvi-
ously this goal can be achieved only if self-vaccina-
tion is rendered attractive to the target species, e.g.,
by the incorporation of an oral vaccine into a bait.
A breakthrough came when Baer, Debbie, and Abel-
seth [2, 3] discovered that some carnivores can be
vaccinated orally with certain attenuated strains of
rabies virus.
The goal of rabies control in wild animals should
be local eradication or inhibition of spread into unin-
fected areas. The desired herd immunity can be es-
tablished in a population only when the following
technical criteria are met: (l) a vaccine that is safe
and potent for field application; (2) a vaccine deliv-
ery system that assures vaccine contact with oral or
intestinal mucosa; (3) an attractive vaccine vehicle
or bait; and (4) an effective spatial and temporal pat-
tern of bait distribution.
The technical assistance of Heidi Gerber, Ursula Gehri, Ruth
Kipfer, Marlies Kohler, and Susanne Schwab is greatly appreciated.
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Uinggass-Strasse 122, CH-3012 Bern, Switzerland.
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Concepts, Models, and Predictions
The coexistence of rabies virus and its main host spe-
cies is dependent on characteristics of the host popu-
lation and rates of virus transmission. A rabid ani-
mal must, on average, infect one or more other
individuals if the disease is to be maintained in the
population [4, 5]. The question of how many animals
in a population must be immune for the basic re-
productive rate of infection to fall below this trans-
mission threshold has been studied via mathemati-
cal models. Some models give rather encouraging
answers [6, 7], whereas others make rabies eradica-
tion seem a nearly unattainable goal [8]. All of the
models described so far in the literature take into
account the dependence of the basic reproductive
rate on population density, but most fail to consider
that populations of foxes (the species targeted in our
studies) are highly structured socially and live in
structured habitats where disease transmission may
not occur randomly [9]. Empiric data collected dur-
ing dog vaccination campaigns suggest that rabies
in dogs disappears when ""70010 of the population
is immune. However, since the social organization
of dog populations is quite different from the be-
havior allowing infectious contacts in a fox popula-
tion, this percentage should not necessarily be taken
as the desired target figure.
Vaccines and Vaccine Virus Pathogenicity
A vaccine to be used for free-living wild animals
should comply with a number of requirements (ta-
ble 1). The first demonstration that foxes can be im-
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Table 1. Requirements for a live attenuated rabies vac-
cine to be used for the immunization of free-living wild
animals.
(1) Should orally immunize target animals.
(2) Should not be pathogenic for humans, for the target species,
and for other species eating bait.
(3) Should not be excreted.
(4) Should not easily revert to higher pathogenicity.
(5) Should be free from pathogenic contamination.
(6) Should be storable.
(7) Should be stable at environmental temperatures for several
days, but not for prolonged periods.
(8) Should be easy and inexpensive to produce.
(9) Should bear at least one genetic marker.
munized orally against rabies was made with the
SAD (Street Alabama Dufferin) strain of rabies vi-
rus [2, 3, 10, 11]. SAD virus must infect oral and pha-
ryngeal tissues to elicit an immune response. Al-
though the virus is destroyed in the stomach [12],
intact vaccine virus in the intestinal tract is capable
of inducing immune responses [13]. Thus, to be ef-
fectively introduced into the intestine, the vaccine vi-
rus must be lyophilized and enterically coated. This
procedure is complicated and expensive. For oral in-
troduction, liquid vaccine must be enclosed in con-
tainers that, when ruptured, deliver it to mucous
membranes in the oral cavity before it is swallowed.
SAD virus has some residual pathogenicity for a
variety of rodent species tested [14-16]. It can also
kill domestic animals and wild carnivores that have
an impaired immune response, e.g., due to distem-
per in dogs ([17] and unpublished results from the
Swiss Rabies Centre, Bern). So far, SAD virus has
been reisolated from two animals. The isolate, in-
jected into healthy animals, induced immunity and
not disease (unpublished results, Swiss Rabies
Centre). Neither laboratory studies nor field experi-
ments have given any indication that the virus could
be propagated within a population or community
of wild animals [18].
Neither of the two other widely known attenuated
rabies strains is a candidate for the immunization
of wild animals. LEP OOW egg passage) virus is too
pathogenic (R. L. Parker, quoted in [1]), while HEP
(high egg passage) virus is not efficacious enough
[19] and easily reverts to higher pathogenicity [20].
It is possible to immunize an animal orally with
inactivated vaccine. Highly concentrated antigen
must be transported intact through the stomach and
into the small intestine. A series of booster doses is
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Table 2. Requirements for baits to be used as vehicles
for a live attenuated rabies vaccine.
(1) Should be attractive to the target species.
(2) Should be eaten without being stored.
(3) Should be rejected by other species (including humans).
(4) Should reach a large proportion of the target population.
(5) Should not inactivate the vaccine.
(6) Should deliver the vaccine into the oral cavity.
(7) Should be able to incorporate a biologic marker (e.g., tetra-
cycline).
(8) Should be easily available and inexpensive.
required before the animal manifests a detectable im-
mune response [13]. Oral immunization of wild
animals with killed vaccine is clearly not the method
of choice until new technologies allow the efficient
transfer of swallowed antigens through the intestines
to immunocompetent cells.
Baits and Vaccine Delivery Systems
The most important qualities that make a bait an
effective vehicle for rabies vaccine are listed in table
2. Although a wide variety of baits have been tested
in the field, only a few results have been published
[21-24]. All bait types tested so far are attractive to
various domestic and wild carnivores but often are
also eaten by rodents [23], the animals most vulner-
able to the residual pathogenicity of SAD virus. Most
bait types also inactivate the vaccine virus. An ex-
ception are the chicken-egg baits suggested by Deb-
bie [21]. These are well accepted by foxes but are then
stored for prolonged periods. The problem of inac-
tivation in meat and tallow baits can be solved by
placing the vaccine in a container that is ruptured
during bait uptake. However, another problem then
arises: foxes often reject vaccine containers incor-
porated into otherwise texturally homogeneous baits.
Considerable effort has therefore been expended in
the development of a container that delivers the vac-
cine into the oral cavity before it is swallowed or re-
jected [25, 26].
Field Application of Baits
For maximal efficiency in a baiting campaign, the
greatest possible proportion of the baits distributed
should be picked up by the target species and not
by competitors, and the greatest possible proportion
of the target population should eat the bait before
the vaccine has lost its potency. Thus, temporal and
Wildlife Immunization Against Rabies
spatial bait distribution strategies are required. The
relation of bait location in a habitat to its subsequent
discovery and acceptance by the target species has
been studied for Swiss foxes [23]. No great differ-
ences were found in the rates of acceptance of baits
placed within forests, along forest edges, and in fields
and meadows. The findings might be entirely differ-
ent, however, in other habitats with other compet-
ing food resources. For foxes living in permanent
family territories, it is probably better to disperse the
baits uniformly (rather than clustered at bait stations)
so that every individual has access to a few baits [27].
Randomly distributed baits might be placed by hand
on the ground [28]·or spread from an airplane [24].
Whether caching the baits or promotion of their visi-
bility is better again depends on characteristics of
the target species, on the presence of food sources
other than the baits, and on the presence of other
animals competing for baits. An additional point to
be considered is the residual pathogenicity of live
attenuated virus. Baits should be laid out in a fash-
ion minimizing the number of undesired contacts
of humans with the vaccine.
Initial Field Applications of Vaccine Bait
Co-workers at the Swiss Rabies Centre and the Ver-
tebrate Biology Unit of the Zoological Institute of
the University of Bern have carried out a number
of field and laboratory studies aimed at the devel-
opment of a system of oral fox vaccination that is
applicable in the field. Franz Steck directed this re-
search until his untimely death in 1982. We thought
that the cloned derivative of one of two SAD strains
received from the Centers for Disease Control in At-
lanta came closest to meeting safety and immunoge-
nicity requirements [18, 28]. Chicken heads were cho-
sen as baits. A vaccine container delivering the
vaccine into the oral cavity of a fox chewing the bait
was developed [26]. The immunizing capabilities of
this system proved to be excellent in captive foxes.
A 150-mg dose of tetracycline, injected into each bait,
was sufficient to "label" the bones of bait consumers,
thus allowing us to establish the percentage of foxes
that had taken up at least one bait.
By 1978, the Rhone Valley, which is bounded on
both sides by high mountain chains of the Swiss
Alps, was threatened by the advance of fox rabies
along Lake Geneva toward the valley entrance. This
appeared to be an ideal epidemiologic situation for
testing the efficacy of oral immunization of foxes.
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After consultation with the World Health Organi-
zation, permission was given by the Federal Veteri-
nary Office, the Federal Office of Public Health, and
the respective administrations of Canton Valais for
an initial field trial in the lower Rhone Valley. Dur-
ing mid-October 1978,4,050 vaccine baits were de-
posited over an area of 335 km2 in the region of Mar-
tigny (Canton Valais). The disease did not cross the
resulting barrier, consisting of a fox population of
which f\J60% were immune [28, 29]. For the main-
tenance of a level of herd immunity sufficient to in-
hibit the spread of rabies, the vaccination campaign
was repeated in the spring and autumn of the follow-
ing years. Since there was no direct proof that the
spread of the disease was stopped by the presence
of immune individuals, the experiment had to be
repeated in other, similar situations, where an "im-
mune barrier" could be created in the expected path
of an epizootic wave. In no instance was the barrier
crossed by the epizootic. The repetition of field trials
in Alpine valleys finally freed the entire Swiss Al-
pine area from rabies.
In 1982 we had to decide on how to eradicate the
disease in the Swiss midlands. High mountain ranges
impeded the spread of the disease, and they greatly
facilitated the strategic application of fox vaccina-
tion; this concept of natural and artificial barriers
to disease also was applied to the rest of the coun-
try. We divided Switzerland into epidemiologic com-
partments delineated by natural and artificial ob-
stacles to the spread of rabies, and we freed one
compartment after another by immunizing the fox
population (figure 1).
Today Switzerland is free of rabies except for an
untreated area in the Jura Mountains bordering
France and a small focus in Canton Aargau, south
of the river Aare. We maintain an "immunization
belt" along the borders of areas where rabies is still
endemic.
Conclusions
The most important conclusions from 8 years of field
application of rabies vaccine baits can be summa-
rized as follows: By means of baits, it is possible to
immunize enough free-living foxes to stop the spread
of the disease into rabies-free areas and to eradicate
the disease from an enzootic area. In areas where
these goals were achieved, 50070-80070 of all foxes
were immunized. These figures are based on the
demonstration of antibodies in serum and tetracy-
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Figure 1. Number of diagnosed rabies cases per trimester in northeastern Switzerland (cantons Aargau [east], Ap-
penzell Inner-Rhoden, Appenzell Ausser-Rhoden, St. Gallen, Thurgau, and Zurich; 5,500 km2) and number of vaccine
baits distributed per 6 months. The first rabies case in the area was registered in November 1967 and the last in Novem-
ber 1985, 1 year after the first campaign of fox vaccination covering the total area. (The first vaccination campaign
for part of the area was conducted in October 1983.)
cline in bone of killed foxes. In areas freed from fox
rabies, rabies also disappears from all other species.
The disease does not reappear spontaneously from
an undetected reservoir after fox vaccination cam-
paigns are discontinued. However, rabies may rein-
vade a fox population that is losing immunity as a
result of population turnover.
The present success should not impede further ef-
forts at improving methods of rabies control. We
need oral immunization systems for other important
hosts, such as free-roaming domestic dogs in the de-
veloping world and possibly raccoons, skunks, and
mongooses. In addition, we need other vaccines with
less residual pathogenicity. Some promising results
with recombinant vaccinia virus were recently pub-
lished [30]. Finally, we may need artificial baits (like
those already applied in the Federal Republic of Ger-
many) that are better suited for industrial produc-
tion and storage.
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